
Nexalin stock surged as new clinical data showed its Gen-2 device improved cognition and brain connectivity in mild Alzheimer’s patients without safety concerns. Nexalin Technology Inc. (NASDAQ:...
Nexalin stock surged as new clinical data showed its Gen-2 device improved cognition and brain connectivity in mild Alzheimer’s patients without safety concerns. Nexalin Technology Inc. (NASDAQ:...